Trace and major elements in serum of patients with chronic myelogenous leukemia

被引：0

作者：

C. G. L. Canellas

S. M. F. Carvalho

E. F. O. De Jesus

M. J. Anjos

R. T. Lopes

机构：

[1] Federal University of Rio de Janeiro/COPPE,

[2] Nuclear Instrumentation Laboratory,undefined

[3] Foundation Institute of Hematology,undefined

[4] Federal University of Rio de Janeiro/COPPE,undefined

[5] Nuclear Instrumentation Laboratory; Physics Institute,undefined

[6] UERJ,undefined

[7] Federal University of Rio de Janeiro/COPPE,undefined

[8] Nuclear Instrumentation Laboratory; Physics Institute,undefined

[9] UERJ,undefined

[10] Federal University of Rio de Janeiro/COPPE,undefined

[11] Nuclear Instrumentation Laboratory,undefined

来源：

Journal of Radioanalytical and Nuclear Chemistry | 2006年 / 269卷

关键词：

Healthy Subject; Serum Sample; Elemental Concentration; Major Element; Chronic Myelogenous Leukemia;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

Major and trace elements were determined in serum of patients with chronic myelogenous leukemia (CML) using total reflection X-ray fluorescence induced by synchrotron radiation (SRTXRF). CML affects 1 to 2 people per 100,000 and accounts for 7-20% cases of leukemia. It was possible to determine the concentrations of the following elements: P, S, Cl, K, Ca, Cr, Mn, Fe, Ni, Cu, Zn, Br and Rb. Using analysis of variance (ANOVA) it was observed that the contents of the P, S, Ca, Cr, Mn, Fe, Cu and Rb elements differed significantly at a = 0.05 between groups of healthy subjects and CML patients and also genders (males and females).

引用

页码：631 / 634

页数：3

共 50 条

[31] Correlation of serum trace elements (copper and selenium) in patients with beta thalassemia major in Pakistan
Sharif, Yasir
Irshad, Saba
Tariq, Muhammad Hamza
Qadeer, Muhammad Imran
Sharif, Shahzad
TRACE ELEMENTS AND ELECTROLYTES, 2020, 37 (01) : 17 - 22
[32] Trace elements in serum of patients with chronic renal failure using PIXE technique
Huang, S
Ren, C
TRACE ELEMENTS AND ELECTROLYTES, 2000, 17 (03) : 154 - 155
[33] Chronic Myelogenous Leukemia
Hasserjian, Robert P.
CURRENT CANCER THERAPY REVIEWS, 2012, 8 (01) : 3 - 13
[34] Chronic myelogenous leukemia
Hochhaus, A.
La Rosee, P.
Eigendorff, E.
Ernst, T.
INTERNIST, 2015, 56 (04): : 333 - 343
[35] Chronic myelogenous leukemia
Kalidas, MT
Kantarjian, H
Talpaz, M
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (08): : 895 - 898
[36] Oral idarubicin in patients with late chronic phase chronic myelogenous leukemia or chronic myelomonocytic leukemia
Giles, FJ
Wong, GC
Clark, SJ
Pierce, S
Kantarjian, HM
Keating, MJ
LEUKEMIA & LYMPHOMA, 2000, 37 (1-2) : 87 - 95
[37] Chronic myelogenous leukemia - Elements of conventional chemotherapy and an overview of autografting in the treatment of the chronic phase
Lauta, VM
MEDICAL ONCOLOGY, 2003, 20 (02) : 95 - 115
[38] Demonstration of a chronic myelogenous leukemia clone in acute myelogenous leukemia
Jeon, Byung Ryul
Kim, Se Hyung
Park, Sung Kyu
Park, Rojin
Hong, Dae Sik
Lee, You Kyoung
BIOMEDICAL RESEARCH-INDIA, 2016, 27 (04): : 1099 - 1101
[39] PSYCHOLOGICAL PROFILE OF CHRONIC MYELOGENOUS LEUKEMIA (CML) PATIENTS
Bajenova, P.
Lomaia, E.
Zaritskey, A.
Schelkova, O.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2010, 95 : 543 - 544
[40] The Biological Basis for Immunotherapy in Patients With Chronic Myelogenous Leukemia
Pinilla-Ibarz, Javier
Shah, Bijal
Dubovsky, Jason A.
CANCER CONTROL, 2009, 16 (02) : 141 - 152

← 1 2 3 4 5 →